IX Relative Valuation
IX's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, IX is overvalued; if below, it's undervalued.
Historical Valuation
ORIX Corp (IX) is now in the Undervalued zone, suggesting that its current forward PE ratio of 9.05 is considered Undervalued compared with the five-year average of 8.60. The fair price of ORIX Corp (IX) is between 23.99 to 28.92 according to relative valuation methord. Compared to the current price of 20.54 USD , ORIX Corp is Undervalued By 14.40%.
Relative Value
Fair Zone
23.99-28.92
Current Price：20.54
14.40%
Undervalued
Trailing
Forward
P/E
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
0.83
P/B
Median3y
1.17
Median5y
1.00
-1.70
FCF Yield
Median3y
-1.58
Median5y
3.24
Competitors Valuation Multiple
The average P/S ratio for IX's competitors is 7.07, providing a benchmark for relative valuation. ORIX Corp Corp (IX) exhibits a P/S ratio of 1.12, which is -84.23% above the industry average. Given its robust revenue growth of -9.85%, this premium appears unsustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
Revenue Growth
Market Cap
People Also Watch
FAQ
Is ORIX Corp (IX) currently overvalued or undervalued?
What is ORIX Corp (IX) fair value?
How does IX's valuation metrics compare to the industry average?
What is the current P/B ratio for ORIX Corp (IX) as of May 24 2025?
What is the current FCF Yield for ORIX Corp (IX) as of May 24 2025?
What is the current Forward P/E ratio for ORIX Corp (IX) as of May 24 2025?